The confluence of tech and biotech holds the promise of faster, more personalized treatments for patients as well as for more resilient, nutritious foods.
As advances in machine learning (ML) and artificial intelligence (AI) rapidly leap forward, they are unlocking previously impossible opportunities in the life sciences, such as finding novel biological targets and designing better drugs. The confluence of tech and biotech holds the promise of faster, more personalized treatments for patients as well as for more resilient, nutritious foods.